261 related articles for article (PubMed ID: 26873333)
1. Assessing biocompatibility of graphene oxide-based nanocarriers: A review.
Kiew SF; Kiew LV; Lee HB; Imae T; Chung LY
J Control Release; 2016 Mar; 226():217-28. PubMed ID: 26873333
[TBL] [Abstract][Full Text] [Related]
2. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake.
Zhang H; Peng C; Yang J; Lv M; Liu R; He D; Fan C; Huang Q
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1761-7. PubMed ID: 23402618
[TBL] [Abstract][Full Text] [Related]
3. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
[TBL] [Abstract][Full Text] [Related]
4. Graphene and graphene oxide as new nanocarriers for drug delivery applications.
Liu J; Cui L; Losic D
Acta Biomater; 2013 Dec; 9(12):9243-57. PubMed ID: 23958782
[TBL] [Abstract][Full Text] [Related]
5. Endoperoxides Revealed as Origin of the Toxicity of Graphene Oxide.
Pieper H; Chercheja S; Eigler S; Halbig CE; Filipovic MR; Mokhir A
Angew Chem Int Ed Engl; 2016 Jan; 55(1):405-7. PubMed ID: 26549205
[TBL] [Abstract][Full Text] [Related]
6. A systems toxicology approach to the surface functionality control of graphene-cell interactions.
Chatterjee N; Eom HJ; Choi J
Biomaterials; 2014 Jan; 35(4):1109-27. PubMed ID: 24211078
[TBL] [Abstract][Full Text] [Related]
7. Amine-modified graphene: thrombo-protective safer alternative to graphene oxide for biomedical applications.
Singh SK; Singh MK; Kulkarni PP; Sonkar VK; Grácio JJ; Dash D
ACS Nano; 2012 Mar; 6(3):2731-40. PubMed ID: 22376049
[TBL] [Abstract][Full Text] [Related]
8. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
[TBL] [Abstract][Full Text] [Related]
9. Selective Accelerated Proliferation of Malignant Breast Cancer Cells on Planar Graphene Oxide Films.
Kenry ; Chaudhuri PK; Loh KP; Lim CT
ACS Nano; 2016 Mar; 10(3):3424-34. PubMed ID: 26919537
[TBL] [Abstract][Full Text] [Related]
10. The Structure-Properties-Cytotoxicity Interplay: A Crucial Pathway to Determining Graphene Oxide Biocompatibility.
Dziewięcka M; Pawlyta M; Majchrzycki Ł; Balin K; Barteczko S; Czerkawska M; Augustyniak M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065593
[TBL] [Abstract][Full Text] [Related]
11. Preparation of hollow core/shell Fe
Wang J; Fang J; Fang P; Li X; Wu S; Zhang W; Li S
J Biomater Sci Polym Ed; 2017 Mar; 28(4):337-349. PubMed ID: 27931160
[TBL] [Abstract][Full Text] [Related]
12. [Research progress of graphene-based materials in the application to biomedicine].
Jiang H; Wang XM; Wang CS
Yao Xue Xue Bao; 2012 Mar; 47(3):291-8. PubMed ID: 22645751
[TBL] [Abstract][Full Text] [Related]
13. Can graphene oxide cause damage to eyesight?
Yan L; Wang Y; Xu X; Zeng C; Hou J; Lin M; Xu J; Sun F; Huang X; Dai L; Lu F; Liu Y
Chem Res Toxicol; 2012 Jun; 25(6):1265-70. PubMed ID: 22587431
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Influence of Graphene and Graphene Oxide on the Immune System Under In Vitro and In Vivo Conditions.
Dudek I; Skoda M; Jarosz A; Szukiewicz D
Arch Immunol Ther Exp (Warsz); 2016 Jun; 64(3):195-215. PubMed ID: 26502273
[TBL] [Abstract][Full Text] [Related]
15. Functionalized graphene oxide as nanocarrier for loading and delivery of ellagic Acid.
Kakran M; Sahoo NG; Bao H; Pan Y; Li L
Curr Med Chem; 2011; 18(29):4503-12. PubMed ID: 21864287
[TBL] [Abstract][Full Text] [Related]
16. Systematic Assessment of the Toxicity and Potential Mechanism of Graphene Derivatives In Vitro and In Vivo.
Li J; Zhang X; Jiang J; Wang Y; Jiang H; Zhang J; Nie X; Liu B
Toxicol Sci; 2019 Jan; 167(1):269-281. PubMed ID: 30239936
[TBL] [Abstract][Full Text] [Related]
17. Graphene oxide: a carrier for pharmaceuticals and a scaffold for cell interactions.
Durán N; Martinez DS; Silveira CP; Durán M; de Moraes AC; Simões MB; Alves OL; Fávaro WJ
Curr Top Med Chem; 2015; 15(4):309-27. PubMed ID: 25579346
[TBL] [Abstract][Full Text] [Related]
18. Crucial Role of Lateral Size for Graphene Oxide in Activating Macrophages and Stimulating Pro-inflammatory Responses in Cells and Animals.
Ma J; Liu R; Wang X; Liu Q; Chen Y; Valle RP; Zuo YY; Xia T; Liu S
ACS Nano; 2015 Oct; 9(10):10498-515. PubMed ID: 26389709
[TBL] [Abstract][Full Text] [Related]
19. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung.
Duch MC; Budinger GR; Liang YT; Soberanes S; Urich D; Chiarella SE; Campochiaro LA; Gonzalez A; Chandel NS; Hersam MC; Mutlu GM
Nano Lett; 2011 Dec; 11(12):5201-7. PubMed ID: 22023654
[TBL] [Abstract][Full Text] [Related]
20. From the Cover: Potentiation of Drug-Induced Phospholipidosis In Vitro through PEGlyated Graphene Oxide as the Nanocarrier.
Yang L; Zhong X; Li Q; Zhang X; Wang Y; Yang K; Zhang LW
Toxicol Sci; 2017 Mar; 156(1):39-53. PubMed ID: 28013220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
